Jazz Pharmaceuticals Shares Outstanding 2007-2018 | JAZZ

Current and historical number of shares outstanding for Jazz Pharmaceuticals (JAZZ) over the last 10 years.
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.000B $1.619B
Jazz Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on identifying, developing and commercializing innovative products to meet unmet medical needs in neurology and psychiatry. Company's goal is to build a broad portfolio of products through a combination of internal development and acquisition/in-licensing activities and to utilize our specialty sales force to promote products in our target markets. They apply novel formulations and drug delivery technologies to known drug compounds, and compounds with the same mechanism of action or similar chemical structure as marketed products, to improve patient care by improving efficacy, reducing adverse side effects or increasing patient compliance relative to existing therapies. Based in Palo Alto, California, the company is committed to working closely with patients, patient advocacy groups and healthcare professionals.
Stock Name Country Market Cap PE Ratio
Shire (SHPG) Ireland $52.299B 11.19
Zoetis (ZTS) United States $40.925B 32.28
Grifols (GRFS) Spain $14.653B 18.99
Neurocrine Biosciences (NBIX) United States $9.110B 0.00
Nektar Therapeutics (NKTR) United States $8.191B 0.00
Sage Therapeutics (SAGE) United States $7.835B 0.00
Catalent (CTLT) United States $5.716B 26.62
Ionis Pharmaceuticals (IONS) United States $5.557B 0.00
United Therapeutics (UTHR) United States $5.323B 9.66
FibroGen (FGEN) United States $5.266B 0.00
Loxo Oncology (LOXO) United States $5.263B 0.00
Taro Pharmaceutical Industries (TARO) Israel $4.522B 18.53
Madrigal Pharmaceuticals (MDGL) United States $4.104B 0.00
Ironwood Pharmaceuticals (IRWD) United States $3.163B 0.00
Aerie Pharmaceuticals (AERI) United States $2.883B 0.00
Heron Therapeutics (HRTX) United States $2.788B 0.00
Portola Pharmaceuticals (PTLA) United States $2.651B 0.00
USANA Health Sciences (USNA) United States $2.623B 25.23
Spectrum Pharmaceuticals (SPPI) United States $2.397B 0.00
Endo (ENDP) Ireland $2.363B 3.22
Enanta Pharmaceuticals (ENTA) United States $2.332B 43.07
Xencor (XNCR) United States $2.253B 0.00
TESARO (TSRO) United States $2.223B 0.00
Zogenix (ZGNX) United States $2.147B 0.00
PTC Therapeutics (PTCT) United States $1.676B 0.00
Corcept Therapeutics (CORT) United States $1.628B 27.17
Pacira Pharmaceuticals (PCRX) United States $1.493B 0.00
TherapeuticsMD (TXMD) United States $1.425B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.414B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $1.384B 0.00
Impax Laboratories (AMRX) United States $1.369B 29.41
ImmunoGen (IMGN) United States $1.329B 0.00
Radius Health (RDUS) United States $1.306B 0.00
TRICIDA INC (TCDA) United States $1.167B 0.00
Endocyte (ECYT) United States $1.147B 0.00
Esperion Therapeutics (ESPR) United States $1.129B 0.00
OptiNose (OPTN) United States $1.022B 0.00
Flexion Therapeutics (FLXN) United States $1.015B 0.00
Karyopharm Therapeutics (KPTI) United States $0.914B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.794B 0.00
GlycoMimetics (GLYC) United States $0.675B 0.00
CASI Pharmaceuticals (CASI) United States $0.645B 0.00
Collegium Pharmaceutical (COLL) United States $0.641B 0.00
Dova Pharmaceuticals (DOVA) United States $0.641B 0.00
Odonate Therapeutics (ODT) United States $0.639B 0.00
Aclaris Therapeutics (ACRS) United States $0.634B 0.00
ChemoCentryx (CCXI) United States $0.625B 43.83
BioCryst Pharmaceuticals (BCRX) United States $0.613B 0.00
TRANSLATE BIO (TBIO) United States $0.582B 0.00
Akebia Therapeutics (AKBA) United States $0.572B 0.00
Siga Technologies (SIGA) United States $0.568B 0.00
Depomed (DEPO) United States $0.520B 0.00
ArQule (ARQL) United States $0.505B 0.00
Majesco Entertainment (COOL) United States $0.492B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.483B 0.00
Lannett Co Inc (LCI) United States $0.477B 4.39
Synergy Pharmaceuticals (SGYP) United States $0.466B 0.00
FORTY SEVEN INC (FTSV) United States $0.460B 0.00
VERRICA PHARMA (VRCA) United States $0.460B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.453B 0.00
Dermira (DERM) United States $0.449B 0.00
Concert Pharmaceuticals (CNCE) United States $0.391B 0.00
Mast Therapeutics (SVRA) United States $0.381B 0.00
XERIS PHARMA (XERS) United States $0.363B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.342B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.336B 26.24
Catalyst Pharmaceuticals (CPRX) United States $0.331B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.319B 0.00
Minerva Neurosciences (NERV) United States $0.318B 0.00
Achaogen (AKAO) United States $0.316B 0.00
NEON THERAPEUTC (NTGN) United States $0.312B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.301B 0.00
Tyme Technologies (TYME) United States $0.292B 0.00
Zafgen (ZFGN) United States $0.277B 0.00
Jounce Therapeutics (JNCE) United States $0.254B 0.00
DURECT (DRRX) United States $0.254B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.252B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.244B 0.00
Redhill Biopharma (RDHL) Israel $0.241B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.239B 0.00
Ocular Therapeutix (OCUL) United States $0.231B 0.00
CTI BioPharma (CTIC) United States $0.231B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.230B 0.00
Galectin Therapeutics (GALT) United States $0.228B 0.00
Ardelyx (ARDX) United States $0.215B 0.00
Zomedica Pharmaceuticals (ZOM) United States $0.214B 0.00
Aratana Therapeutics (PETX) United States $0.210B 0.00
Immune Design (IMDZ) United States $0.209B 0.00
ProNAi Therapeutics (SRRA) Canada $0.205B 0.00
Ampio Pharmaceuticals (AMPE) United States $0.202B 0.00
IMV INC (IMV) Canada $0.201B 0.00
ContraFect (CFRX) United States $0.191B 0.00
Melinta Therapeutics (MLNT) United States $0.190B 0.00
Neos Therapeutics (NEOS) United States $0.187B 0.00
Adherex Technologies (FENC) United States $0.174B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.172B 0.00
Nature's Sunshine Products (NATR) United States $0.172B 0.00
MediWound (MDWD) Israel $0.170B 0.00
Opexa Therapeutics (ACER) United States $0.169B 0.00
Calithera Biosciences (CALA) United States $0.168B 0.00
Aldeyra Therapeutics (ALDX) United States $0.160B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.159B 0.00
MEI Pharma (MEIP) United States $0.156B 0.00
Molecular Templates (MTEM) United States $0.135B 0.00
Cardiome Pharma (CORV) Canada $0.134B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.132B 0.00
Forward Pharma (FWP) Denmark $0.131B 0.00
Juniper Pharmaceuticals (JNP) United States $0.127B 190.00
SteadyMed (STDY) Israel $0.120B 0.00
Iterum Therapeutics (ITRM) Ireland $0.119B 0.00
Infinity Pharmaceuticals (INFI) United States $0.114B 0.00
Nivalis Therapeutics (ALPN) United States $0.113B 0.00
Otonomy (OTIC) United States $0.110B 0.00
Recro Pharma (REPH) United States $0.110B 0.00
Affimed (AFMD) Germany $0.109B 0.00
Rafael Holdings (RFL) United States $0.107B 0.00
BioLineRx (BLRX) Israel $0.098B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.097B 0.00
KalVista Pharmaceuticals (KALV) United States $0.093B 0.00
Actinium Pharmaceuticals (ATNM) United States $0.087B 0.00
SCYNEXIS (SCYX) United States $0.086B 0.00
KemPharm (KMPH) United States $0.078B 0.00
Natural Alternatives (NAII) United States $0.076B 9.81
Novan (NOVN) United States $0.076B 0.00
Trillium Therapeutics (TRIL) Canada $0.074B 0.00
Genocea Biosciences (GNCA) United States $0.067B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.066B 0.00
Champions Oncology (CSBR) United States $0.064B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.062B 0.00
Capnia (SLNO) United States $0.056B 0.00
Mannatechorporated (MTEX) United States $0.056B 13.65
Heat Biologics (HTBX) United States $0.048B 0.00
Avenue Therapeutics (ATXI) United States $0.043B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.041B 37.48
NovaBay Pharmaceuticals (NBY) United States $0.040B 0.00
Xenetic Biosciences (XBIO) United States $0.036B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.036B 0.00
Biomerica (BMRA) United States $0.035B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.035B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.034B 0.00
Onconova Therapeutics (ONTX) United States $0.034B 0.00
HANCOCK JAFFE (HJLI) United States $0.034B 0.00
ProPhase Labs (PRPH) United States $0.034B 3.82
IsoRay (ISR) United States $0.033B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.032B 0.00
Shineco (TYHT) China $0.030B 2.58
Lipocine (LPCN) United States $0.030B 0.00
Regulus Therapeutics (RGLS) United States $0.030B 0.00
NanoViricides (NNVC) United States $0.029B 0.00
Citius Pharmaceuticals (CTXR) United States $0.028B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.025B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.025B 0.00
Can-Fite Biopharma (CANF) Israel $0.024B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.023B 0.00
Cyanotech (CYAN) United States $0.023B 21.94
Aradigm (ARDM) United States $0.023B 0.00
ESSA Pharma (EPIX) Canada $0.022B 0.00
Aviragen Therapeutics (VXRT) United States $0.022B 0.00
Midatech Pharma (MTP) United Kingdom $0.021B 0.00
Intellipharmaceutics (IPCI) Canada $0.020B 0.00
Egalet (EGLT) United States $0.020B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.019B 0.00
Aralez Pharmaceuticals (ARLZ) Canada $0.019B 0.00
Bio-Path Holdings (BPTH) United States $0.018B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.016B 0.00
Pain Therapeutics (PTIE) United States $0.016B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.015B 0.00
India Globalization Capital (IGC) United States $0.014B 0.00
Skyline Medical (AIPT) United States $0.014B 0.00
Jaguar Animal Health (JAGX) United States $0.014B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.012B 0.00
PharmAthene (ALT) United States $0.012B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.012B 0.00
OncoGenex Pharmaceuticals (ACHV) United States $0.010B 0.00
Apricus Biosciences (APRI) United States $0.009B 0.00
RXi Pharmaceuticals (RXII) United States $0.008B 0.00
Biostar Pharmaceuticals (BSPM) China $0.006B 3.36
Bio Blast Pharma (ORPN) Israel $0.005B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.002B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
ELECTROCORE LLC (ECOR) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00